O-RADS MRI:诊断性能与各分类恶性率的系统评价与Meta分析
该研究系统检索2013年5月至2022年9月文献,纳入12项研究共3731名女性4520个附件病变,评估O-RADS MRI对超声不确定附件病变的诊断性能。结果显示汇总敏感度92%、特异度91%,O-RADS MRI 2、3、4、5类恶性率分别为0.1%、6%、60%、96%,4类和5类恶性率高于预期。
要点
- O-RADS MRI对超声不确定附件病变诊断敏感度92%、特异度91%。
- O-RADS MRI 2类恶性率0.1%,3类6%,4类60%,5类96%。
- 4类和5类汇总恶性率高于原预测值,报告时需注意。
核心结论
- 使用O-RADS MRI词典解读盆腔MRI对超声不确定附件病变具有高诊断性能。
- O-RADS MRI 4类和5类的汇总恶性率高于预测值。
研究设计与样本
- 系统评价与Meta分析,检索2013年5月至2022年9月文献。
- 纳入12项研究13个研究部分,共3731名女性4520个附件病变。
- 参考标准为病理检查和/或随访。
- 采用双变量随机效应模型汇总诊断性能,随机效应模型汇总分类恶性率。
诊断标准与关键数值
- 诊断性能Meta分析纳入4012个病变,汇总敏感度92%(95%CI:88,95),汇总特异度91%(95%CI:89,93)。
- 恶性率Meta分析纳入3641个病变,O-RADS MRI 2类恶性率0.1%(95%CI:0,1)。
- O-RADS MRI 3类恶性率6%(95%CI:3,9)。
- O-RADS MRI 4类恶性率60%(95%CI:52,67)。
- O-RADS MRI 5类恶性率96%(95%CI:92,99)。
临床应用与阅片要点
- O-RADS MRI可用于超声不确定附件病变的进一步定性,指导手术决策。
- 报告O-RADS MRI 4类和5类时,应知晓其汇总恶性率高于原预测值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background US-indeterminate adnexal lesions remain an important indication for gynecologic surgery. MRI can serve as a problem-solving tool through the use of the Ovarian-Adnexal Imaging Reporting and Data System (O-RADS) MRI lexicon, which is based on the ADNEX MR scoring system. Purpose To perform a systematic review and meta-analysis of the diagnostic performance of pelvic MRI interpreted using the ADNEX or O-RADS MRI stratification systems to characterize US-indeterminate adnexal lesions and of the category-wise malignancy rates. Materials and Methods A systematic literature search from May 2013 (publication of the ADNEX MR score) to September 2022 was performed. Studies reporting the use of pelvic MRI interpreted with the ADNEX or O-RADS MRI systems to characterize US-indeterminate adnexal lesions, with pathologic examination and/or follow-up as the reference standard, were included. Summary estimates of diagnostic performance were obtained with the bivariate random-effects model, while category-wise summary malignancy rates of O-RADS MRI 2, 3, 4, and 5 lesions were obtained with a random-effects model. Effects of covariates on heterogeneity and diagnostic performance were investigated through meta-regression. Results Thirteen study parts from 12 studies (3731 women, 4520 adnexal lesions) met the inclusion criteria. Diagnostic performance meta-analysis for 4012 lesions found a 92% summary sensitivity (95% CI: 88, 95) and a 91% summary specificity (95% CI: 89, 93). The meta-analysis of malignancy rates for 3641 lesions showed summary malignancy rates of 0.1% (95% CI: 0, 1) among O-RADS MRI 2 lesions, 6% (95% CI: 3, 9) among O-RADS MRI 3 lesions, 60% (95% CI: 52, 67) among O-RADS MRI 4 lesions, and 96% (95% CI: 92, 99) among O-RADS MRI 5 lesions. Conclusion Pelvic MRI interpreted with the Ovarian-Adnexal Reporting and Data System (O-RADS) MRI lexicon had high diagnostic performance for the characterization of US-indeterminate adnexal lesions. Summary estimates of malignancy rates in the O-RADS MRI 4 and O-RADS MRI 5 categories were higher than predicted ones. © RSNA, 2022 Supplemental material is available for this article. See also the editorial by Lee and Kang in this issue.
引用
- Rizzo, Cozzi, Dolciami, et al. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates. Radiology. 2022. PMID: 36413127. doi:10.1148/radiol.220795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。